BARCELONA, Spain - InspireMD, Ltd. announced today the completion of enrolment for the MAGICAL trial (MGuard(TM) in Acute Myocardial). The trial was designed to confirm the clinical feasibility, safety and performance of MGuard when used during Primary PCI in STEMI patients.
LONDON - Year on Year Decline has not Accelerated; 5% Fewer Flights and 2.7% Fewer Seats LONDON, May 20 /PRNewswire/ --
BERLIN - The program of the "International eSports Conference (ESCONF)" taking place in Cologne from May 26th to 27th has been confirmed and addresses students, university students, teachers, parents, politicians and the media this year in addition to eSportsmen and their managers.
LAS VEGAS - Enhancement Allows for Assessment of Virtually Any Negative Traffic, Application Network Layer Testing from Single Unit
LAS VEGAS - Vast Range of Scenarios, User Transactions Added to Latest Version Spirent Avalanche
Older News
S M T W T F S
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
Copyright© 2011 The Gaea Times